Tecentriq® (atezolizumab)
for Lung Cancer

Tecentriq (atezolizumab) is a monoclonal antibody used to treat cancers like non-small cell lung cancer, small cell lung cancer, hepatocellular carcinoma, melanoma, and alveolar soft part sarcoma. It’s a PD-L1 inhibitor that helps the immune system fight cancer by blocking the PD-1/PD-L1 pathway, which cancer cells use to avoid detection. Tecentriq strengthens the immune response against tumor cells.

Heart